We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+20.77%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$547M
Cap. Flow
+$491M
Cap. Flow %
48%
Top 10 Hldgs %
88.16%
Holding
123
New
24
Increased
19
Reduced
32
Closed
28

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$4.7M
2
ZGNX
Zogenix, Inc.
ZGNX
+$3.17M
3
WNC icon
Wabash National
WNC
+$1.87M
4
SAGE
Sage Therapeutics
SAGE
+$1.75M
5
PRTA icon
Prothena Corp
PRTA
+$1.53M

Top Sells

Rank Stock Value
1
HIMX
Himax Technologies
HIMX
+$4.17M
2
MB
MINDBODY, Inc. Class A Common Stock
MB
+$2.9M
3
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$2.74M
4
AMD icon
Advanced Micro Devices
AMD
+$2.52M
5
MYND
Mynd.ai
MYND
+$2.28M

Sector Composition

Rank Sector Weight
1 Healthcare 5.08%
2 Technology 2.88%
3 Communication Services 2.01%
4 Consumer Discretionary 1.64%
5 Industrials 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TITN icon
76
Titan Machinery
TITN
$396M
$529K 0.05%
+25,000
New +$430K
LCTX icon
77
Lineage Cell Therapeutics
LCTX
$269M
$494K 0.05%
262,376
+211,455
+415% +$462K
PRTK
78
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$473K 0.05%
26,400
– –
TELL
79
DELISTED
Tellurian Inc.
TELL
$438K 0.04%
+45,000
New +$482K
SOHU
80
Sohu.com
SOHU
$362M
$434K 0.04%
+10,000
New +$536K
PXLW icon
81
Pixelworks
PXLW
$38.2M
$373K 0.04%
+4,908
New +$333K
PTR
82
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$361K 0.04%
+5,168
New +$347K
SCTL
83
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$352K 0.03%
42,370
– –
SCYX icon
84
SCYNEXIS
SCYX
$48.1M
$329K 0.03%
1,772
– –
COHR icon
85
Coherent
COHR
$51.4B
$282K 0.03%
+6,000
New +$269K
NOAH
86
Noah Holdings
NOAH
$580M
$278K 0.03%
+6,000
New +$247K
VNET
87
VNET Group
VNET
$2.04B
$267K 0.03%
33,486
+11,986
+56% +$87.3K
DCOY
88
Decoy Therapeutics
DCOY
$2.19M
– –
0
– –
BEDU
89
DELISTED
Bright Scholar Education Holdings
BEDU
$202K 0.02%
2,700
-5,925
-69% -$517K
OVID icon
90
Ovid Therapeutics
OVID
$414M
$148K 0.01%
+15,000
New +$138K
ACMR icon
91
ACM Research
ACMR
$5.42B
$131K 0.01%
+75,000
New +$149K
AEHR icon
92
Aehr Test Systems
AEHR
$2.61B
$97K 0.01%
35,908
-22,672
-39% -$71.8K
ZSAN
93
DELISTED
Zosano Pharma Corporation
ZSAN
$78K 0.01%
214
– –
CAPR icon
94
Capricor Therapeutics
CAPR
$223M
$53K 0.01%
3,375
– –
AMD icon
95
Advanced Micro Devices
AMD
$776B
– –
-197,550
Closed -$2.52M
BZUN
96
Baozun
BZUN
$167M
– –
-8,000
Closed -$262K
DQ
97
Daqo New Energy
DQ
$823M
– –
-50,000
Closed -$290K
FENG
98
Phoenix New Media
FENG
$18.3M
– –
-6,115
Closed -$216K
HUM icon
99
Humana
HUM
$43.7B
– –
-5,000
Closed -$1.22M
INCY icon
100
Incyte
INCY
$24.2B
– –
-18,000
Closed -$2.1M
1 2 3
4
5

Similar funds

MAM
Moelis Asset Management New York $5.32M AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
SM
SG3 Management Dorado, Puerto Rico $6.45K AUM 61.81% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

Granite Point Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Granite Point Capital Management held 123 positions worth $1.02B, up 115% from $475M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Granite Point Capital Management deployed $491M of net new capital in Q4 2017, opening 24 new positions and adding to 19 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 40,000 shares worth $5.28M.

By sector, the portfolio is most concentrated in Healthcare at 5.1% of assets, down from 8.5% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Himax Technologies, an estimated $4.17M trimmed.

  • Granite Point Capital Management's largest Q4 2017 buy was GW Pharmaceuticals Plc American Depositary Shares: 40,000 shares worth $5.28M.
  • Granite Point Capital Management added most to Zogenix, Inc. in Q4 2017, an estimated $3.17M increase.
  • Granite Point Capital Management's biggest Q4 2017 reduction was Himax Technologies, cutting an estimated $4.17M.
  • Granite Point Capital Management fully exited MINDBODY, Inc. Class A Common Stock in Q4 2017, selling an estimated $2.9M.
  • Granite Point Capital Management's ten largest holdings make up 88% of its $1.02B portfolio in Q4 2017.
  • Granite Point Capital Management opened 24 new positions and closed 28 in Q4 2017.
  • Granite Point Capital Management's portfolio value rose 115% quarter-over-quarter to $1.02B.

Based on Granite Point Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.